JNJ-56021927
Showing 26 - 50 of 445
Prostate Cancer Trial in Houston (Apalutamide, IHT)
Withdrawn
- Prostate Cancer
-
Houston, TexasUTHealth Memorial Hermann Cancer Center
Feb 25, 2020
Hepatic Impairment Trial in Knoxville, San Antonio (JNJ-56021927)
Completed
- Hepatic Impairment
- JNJ-56021927
-
Knoxville, Tennessee
- +1 more
May 17, 2019
Prostate Cancer Trial in Cambridge (Apalutamide)
Completed
- Prostate Cancer
-
Cambridge, Cambridgeshire, United KingdomCambridge University Hospitals NHS Foundation Trust/Addenbrookes
Nov 18, 2019
Prostatic Tumors Trial in Worldwide (Radiotherapy, LHRHa, Apalutamide)
Recruiting
- Prostatic Neoplasms
- Radiotherapy
- +2 more
-
Tucson, Arizona
- +145 more
Jan 17, 2023
Metastatic Hormone Sensitive Prostate Cancer Treated With
Not yet recruiting
- Metastatic Hormone-sensitive Prostate Cancer
-
Innsbruck, Austria
- +42 more
Jun 5, 2023
Advanced Prostate Cancer Trial in Lyon, Villejuif, Rotterdam (JNJ-78278343, JNJ-87189401)
Not yet recruiting
- Advanced Prostate Cancer
-
Lyon, France
- +2 more
Oct 18, 2023
Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)
Not yet recruiting
- Myeloproliferative Disorders
- +3 more
- (no location specified)
Nov 21, 2023
Metastatic Castration-resistant Prostate Tumors Trial in Australia, Korea, Republic of, United States (JNJ-78278343, Cetrelimab)
Not yet recruiting
- Metastatic Castration-resistant Prostate Neoplasms
-
Sarasota, Florida
- +7 more
Apr 6, 2023
Multiple Myeloma Trial in Belgium, Israel, Spain (Daratumumab, JNJ-63723283)
Completed
- Multiple Myeloma
-
Antwerpen, Belgium
- +12 more
Dec 1, 2022
PSA Progression, Stage III Prostate Adenocarcinoma, Stage IV Prostate Adenocarcinoma Trial in Canada, United States (drug,
Active, not recruiting
- PSA Progression
- +2 more
- Apalutamide
- +2 more
-
Gilbert, Arizona
- +362 more
Mar 9, 2022
Healthy Trial in Leiden (JNJ-69095897, Placebo)
Recruiting
- Healthy
- JNJ-69095897
- Placebo
-
Leiden, NetherlandsCentre for Human Drug Research
Jan 31, 2023
Relapsed or Refractory Multiple Myeloma Trial in Worldwide (JNJ-79635322)
Recruiting
- Relapsed or Refractory Multiple Myeloma
-
Edegem, Belgium
- +16 more
Jan 27, 2023
Multiple Myeloma Trial in Japan, United States (JNJ-68284528)
Completed
- Multiple Myeloma
- JNJ-68284528
-
Phoenix, Arizona
- +20 more
Oct 5, 2022
Carcinoma, Non-small-Cell Lung Trial in New York, Fairfax (JNJ-86974680, Cetrelimab, Radiation Therapy)
Recruiting
- Carcinoma, Non-small-Cell Lung
- JNJ-86974680
- +2 more
-
New York, New York
- +1 more
Nov 8, 2023
Geographic Atrophy, Macular Degeneration Trial in United States (JNJ-81201887, Prednisone, Placebo)
Recruiting
- Geographic Atrophy
- Macular Degeneration
- JNJ-81201887
- +4 more
-
Phoenix, Arizona
- +3 more
Mar 31, 2023